報告題目: “Chemistry of the Large Numbers" 關於如何構建人工免疫系統組以及組合抗體庫的理論和應用
報 告 人:Pro. Richard A. Lerner
美國國家科EON4、美國醫學科EON4及美國藝術與科EON4三院院士
報告時間:2014年9月26日11:00-11:40
報告地點↩️🏀:EON体育4閔行校區生物藥學樓 樹華多功能廳
聯 系 人🙃: 解叢君 This e-mail address is being protected from spambots. You need JavaScript enabled to view it. 譚晶 This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
報告人簡介🦧🧚🏿♀️:
Professor Richard Alan Lerner studied medicine at Northwestern University and Stanford, earning his M.D. He began his career in research in the Department of Experimental Pathology at The Scripps Research Institute in La Jolla (California), which he led from 1986 to 2012. Richard Lerner’s career in science is one of the most distinguished and decorated. His discoveries and contributions are numerous, including pioneering development of tailor-made catalytic antibodies used as enzyme to accelerate chemical reactions. Additionally, Professor Lerner described the selection and production of monoclonal antibodies with desired biological properties without the need for immunization of animals in 1991 and this method has remained the most efficient way to generate fully human therapeutic antibodies. Professor Lerner is the author of more than 400 scientific publications and holds honorary degrees from seven universities in Europe and America. He has also received numerous prestigious scientific awards, Richard Lerner is also a member of the U.S. National Academy of Sciences. Prof. Richard Lerner was appointed as Founding Director of Shanghai Institute for Advanced Immunochemical Studies (SIAIS) of ShanghaiTech University in October,2012.
Richard A. Lerner教授在美國西北大學與斯坦福大學學習藥學🐦,獲醫學博士學位。1986年至2012年間,Lerner教授在加州Scripps研究所病理實驗部從事研究工作,並擔任所長。Lerner教授在科學領域的貢獻舉世矚目🏋🏼,他的發現和研究成果為數眾多,其中包括先驅性的項目—開發出特製的作為酶的催化抗體🧑🏽🎓,用於加速化學反應🦹🏼♀️。此外, 1991年,Lerner教授描述了不需動物免疫💅⛷、具有所需生物屬性的單克隆抗體的選擇與製備方法,這種方法目前仍然是製備人類治療性抗體的最有效的方法。Lerner教授共發表四百多篇學術論文,擁有歐洲與美國7所大學的名譽博士學位,獲得眾多極具聲望的科學獎項,是美國國家科EON4⤵️、美國醫學科EON4及美國藝術與科EON4三院院士。2012年10月♣︎,Lerner教授正式受聘擔任上海科技大學免疫化學研究所首任所長。